CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities.
Chief Executive Officer
Mr. Dowling was appointed as Chief Executive Officer of the Company in May 2018. Prior to his appointment as CEO, Mr. Dowling held the position of CFO with the Company since 2014. Prior to 2014, Mr. Dowling held numerous senior positions including President and Chief Financial Officer of MediVas, LLC, a biotechnology company focused on drug formulation and delivery from 2005 to 2013 where he led day-to-day operations, drug research and development, product development and commercialization and strategic alliance building including license agreements with Pfizer, Merck, Wyeth, DSM, Guidant and Boston Scientific. Mr. Dowling also served as a Managing Director at Citigroup, a global financial services firm, and earlier in his career served various operating, finance and accounting roles in both public accounting and in the banking industry. Mr. Dowling graduated from University of California, Los Angeles in Economics and is a certified public accountant.
Chief Financial Officer
Mr. Grasser has more than 20 years of experience and an extensive background in accounting, finance, financial reporting and operations. Prior to his role at CV Sciences, Mr. Grasser was Controller at Ballast Point Brewing, a subsidiary of Constellation Brands, Inc. from 2015 to 2018. Prior to his role at Ballast Point, Mr. Grasser held senior finance positions with Sequenom, Inc. from 2014 to 2015 and Peregrine Semiconductor Corporation from 2010 to 2014. Mr. Grasser began his career at KPMG LLP providing audit and IT advisory services, advancing to senior audit manager. Mr. Grasser has an MBA from the Keller Graduate School of Management, a BA from University of Regensburg and is a Certified Public Accountant.
Chief Operating Officer, Co-Founder
Mr. Mona III co-founded CV Sciences in 2012 and has been instrumental in developing the worldwide supply chain for hemp products. Mr. Mona III’s expertise in hemp farming, processing, testing and product development of more than 50 novel hemp-based CBD products has directly led to the Company’s successful consumer products division. Mr. Mona III’s leadership role in the U.S. Hemp Roundtable was critical in advancing the Agriculture Improvement Act of 2018, pivotal legislation better known as the “2018 Farm Bill”, which was signed into law in December 2018. As the Company’s Chief Operating Officer, Mr. Mona III is now leading the next phase of the Company’s global supply chain initiative with commencement of commercial hemp farming in the U.S. Mr. Mona III graduated from the University of San Diego in Business Administration.
Vice President, Human Nutrition
Mr. Tomc is a recognized authority on dietary supplements, with twenty years of experience in the nutritional health industry. Formerly the Vice President of North American Herb and Spice, where he served for 10 years, in addition to his service as Global Educator for omega-3 market leader, Nordic Naturals, Mr. Tomc is known for his extensive print interviews and contributions to noted books on integrative medicine, as well as his 4000 radio appearances. A renowned educator, Mr.Tomc recognizes CBD and its multiple mechanisms of action to support human health, and envisions a new category of dietary supplements derived from agricultural hemp.
Senior Vice President of Scientific and Regulatory Affairs
Dr. MacKay serves on the advisory board for the American Botanical Council, the NSF International Joint Committee on Dietary Supplements, and the NIST/NIH Dietary Supplement Laboratory Quality Assurance Program. He is a licensed naturopathic doctor and previously was owner and practitioner in a New Hampshire-based integrative medical practice. Additionally, Dr. MacKay is on the editorial board of three peer-reviewed publications: the official publication of the American Association of Naturopathic Physicians, Natural Medicine Journal, Integrative Medicine—a Clinician’s Journal, and Current Topics in Nutraceutical Research. Dr. MacKay is also Chair of the Steering Committee for the SIDI Work Group.
Dr. MacKay holds a bachelor’s in Marine Biology from the University of California, Santa Cruz and his N.D. from the National College of Natural Medicine in Portland, Oregon.